201 related articles for article (PubMed ID: 26539004)
1. Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
Kim SI; Lee Y; Son Y; Jun SY; Yun S; Bae HS; Lim MC; Jung SY; Joo J; Lee ES
J Korean Med Sci; 2015 Nov; 30(11):1604-10. PubMed ID: 26539004
[TBL] [Abstract][Full Text] [Related]
2. The Author's Response: Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
Kim SI; Lim MC; Lee ES
J Korean Med Sci; 2016 Apr; 31(4):647. PubMed ID: 27051254
[No Abstract] [Full Text] [Related]
3. Letter to the Editor: Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use: Scientific Views.
Das S; Mahakkanukrauh P
J Korean Med Sci; 2016 Apr; 31(4):646. PubMed ID: 27051253
[No Abstract] [Full Text] [Related]
4. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study.
Tsai YT; Lai JN; Wu CT
J Ethnopharmacol; 2014 Sep; 155(2):1256-62. PubMed ID: 25048609
[TBL] [Abstract][Full Text] [Related]
5. Use of a decision aid did not decrease decisional conflict in patients with carpal tunnel syndrome.
Gong HS; Park JW; Shin YH; Kim K; Cho KJ; Baek GH
BMC Musculoskelet Disord; 2017 Mar; 18(1):118. PubMed ID: 28320368
[TBL] [Abstract][Full Text] [Related]
6. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
7. Should tamoxifen users be screened for endometrial lesions?
Neven P; Vergote I
Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
[No Abstract] [Full Text] [Related]
8. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
Barakat RR
J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
[No Abstract] [Full Text] [Related]
9. Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
Sanft T; Aktas B; Schroeder B; Bossuyt V; DiGiovanna M; Abu-Khalaf M; Chung G; Silber A; Hofstatter E; Mougalian S; Epstein L; Hatzis C; Schnabel C; Pusztai L
Breast Cancer Res Treat; 2015 Dec; 154(3):533-41. PubMed ID: 26578401
[TBL] [Abstract][Full Text] [Related]
10. Should women receiving tamoxifen be screened for endometrial cancer? An argument for screening.
Menzin AW; Gal D; Barakat RR
Cancer Invest; 2000; 18(8):793-7. PubMed ID: 11107449
[No Abstract] [Full Text] [Related]
11. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and risk of endometrial cancer.
Marsh F; Mayfield M
Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
[No Abstract] [Full Text] [Related]
13. Tamoxifen and risk of endometrial cancer.
Kairies P
Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
[No Abstract] [Full Text] [Related]
14. Tamoxifen and risk of endometrial cancer.
Lasset C; Bonadona V; Mignotte H; Brémond A
Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
[No Abstract] [Full Text] [Related]
15. Tamoxifen and risk of endometrial cancer.
Atkins CD
Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
[No Abstract] [Full Text] [Related]
16. Tamoxifen and risk of endometrial cancer.
Tempfer C; Kubista E
Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
[No Abstract] [Full Text] [Related]
17. Tamoxifen and risk of endometrial cancer.
Narod SA; Pal T; Graham T; Mitchell M; Fyles A
Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
[No Abstract] [Full Text] [Related]
18. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
[No Abstract] [Full Text] [Related]
19. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
McCaul KA
Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
[No Abstract] [Full Text] [Related]
20. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
